IN8bio, Inc. (INAB)
1.87
+0.07
(+3.89%)
USD |
NASDAQ |
May 29, 16:00
1.81
-0.06
(-3.21%)
After-Hours: 20:00
IN8bio EPS Diluted (Quarterly) : -0.2615 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Calidi Biotherapeutics, Inc. | -0.4285 |
| Connect Biopharma Holdings Ltd. | -0.343 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.09M |
| Total Expenses (Quarterly) | 5.09M |
| Enterprise Value | -11.10M |
| Earnings Yield | -152.6% |
| Normalized Earnings Yield | -152.59 |